Patient reported symptoms during an ulcerative colitis flare: A Qualitative Focus Group Study

European Journal of Gastroenterology and Hepatology

Volumn 21, Issue 5, 2009, Pages 558-564

  Waljee, Akbar K ^a   Joyce, Joel C ^b   Wren, Patricia A ^c   Khan, Tahira M ^a   Higgins, Peter D R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c OAKLAND UNIVERSITY   (United States)

Author keywords

Focus groups; Inflammatory bowel disease; Patient reported outcomes; Qualitative research; Symptom domains; Ulcerative colitis

Indexed keywords

IMMUNOMODULATING AGENT; INFLIXIMAB; MESALAZINE; STEROID;

ADULT; AGED; ANUS CONTINENCE; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEFECATION; DISEASE ACTIVITY; DISEASE SEVERITY; ENDOSCOPY; FEMALE; HUMAN; MALE; OCCULT BLOOD; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; ULCERATIVE COLITIS;

ACUTE DISEASE; ADULT; AGED; ANXIETY; ATTITUDE TO HEALTH; COLITIS, ULCERATIVE; COLONOSCOPY; DEFECATION; FECAL INCONTINENCE; FECES; FEMALE; FOCUS GROUPS; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; MUSCLE CRAMP; PATIENT-CENTERED CARE; PSYCHOMETRICS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 67651163461     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328326cacb     Document Type: Article

References (24)

1. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 2004; 126: 1504-1517. (Pubitemid 38649869)
2. Irvine EJ. Review article: patients' fears and unmet needs in inflammatory bowel disease. Aliment Pharmacol Ther 2004; 20 (Suppl 4):54-59. (Pubitemid 39319248)
3. Longobardi T, Jacobs P, Bernstein CN. Work losses related to inflammatory bowel disease in the United States: results from the National Health Interview Survey. Am J Gastroenterol 2003; 98:1064-1072. (Pubitemid 36733768)
4. Casellas F, Lopez-Vivancos J, Casado A, Malagelada JR. Factors affecting health related quality of life of patients with inflammatory bowel disease. Qual Life Res 2002; 11:775-781. (Pubitemid 35388174)
5. Leijonmarck CE, Persson PG, Hellers G. Factors affecting colectomy rate in ulcerative colitis: an epidemiologic study. Gut 1990; 31:329-333. (Pubitemid 20093673)
6. Waljee A, Waljee J, Morris AM, Higgins PD. Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut 2006; 55:1575-1580. (Pubitemid 44629206)
7. Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 1955; 2:1041-1048.
8. Powell-Tuck J, Bown RL, Lennard-Jones JE. A comparison of oral prednisolone given as single or multiple daily doses for active proctocolitis. Scand J Gastroenterol 1978; 13:833-837.
9. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987; 317:1625-1629.
10. Sutherland LR, Martin F, Greer S, Robinson M, Greenberger N, Saibil F, et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 1987; 92: 1894-1898. (Pubitemid 17072238)
11. Seo M, Okada M, Yao T, Ueki M, Arima S, Okumura M. An index of disease activity in patients with ulcerative colitis. Am J Gastroenterol 1992; 87: 971-976.
12. Walmsley RS, Ayres RC, Pounder RE, Allan RN. A simple clinical colitis activity index. Gut 1998; 43:29-32.
13. Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70:439-444.
14. Barry CA, Stevenson FA, Britten N, Barber N, Bradley CP. Giving voice to the lifeworld. More humane, more effective medical care? A qualitative study of doctor-patient communication in general practice. Soc Sci Med 2001; 53:487-505.
15. Welfare MR, Colligan J, Molyneux S, Pearson P, Barton JR. The identification of topics for research that are important to people with ulcerative colitis. Eur J Gastroenterol Hepatol 2006; 18:939-944. (Pubitemid 44213035)
16. Strandberg EL, Ovhed I, Borgquist L, Wilhelmsson S. The perceived meaning of a (w)holistic view among general practitioners and district nurses in Swedish primary care: a qualitative study. BMC Fam Pract 2007; 8:8. (Pubitemid 46434558)
17. Sandelowski M, Barroso J. Writing the proposal for a qualitative research methodology project. Qual Health Res 2003; 13:781-820. (Pubitemid 44534763)
18. Azzolini F, Pagnini C, Camellini L, Scarcelli A, Merighi A, Primerano AM, et al. Proposal of a new clinical index predictive of endoscopic severity in ulcerative colitis. Dig Dis Sci 2005; 50:246-251. (Pubitemid 40311527)
19. Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994; 330:1841-1845. (Pubitemid 24188135)
20. Seo M, Okada M, Yao T, Okabe N, Maeda K, Oh K. Evaluation of disease activity in patients with moderately active ulcerative colitis: comparisons between a new activity index and Truelove and Witts' classification. Am J Gastroenterol 1995; 90:1759-1763.
21. Minderhoud IM, Oldenburg B, Wismeijer JA, Van Berge Henegouwen GP, Smout AJ. IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci 2004; 49:469-474. (Pubitemid 38453568)
22. Keohane J, O'Mahony C, O'Mahony L, O'Mahony S, Quigley E, Shanahan F. Co-existence of IBS-related symptoms in patients with Crohn's disease-A real association of a reflection of occult inflammation? Gastroenterology 2007; 134:A187.
23. Rhodes JM. The role of Escherichia coli in inflammatory bowel disease. Gut 2007; 56:610-612. (Pubitemid 46662923)
24. Higgins PD, Schwartz M, Mapili J, Zimmermann EM. Is endoscopy necessary for the measurement of disease activity in ulcerative colitis? Am J Gastroenterol 2005; 100:355-361.